Success Metrics

Clinical Success Rate
100.0%

Based on 39 completed trials

Completion Rate
100%(39/39)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
1
3%
Ph phase_1
6
15%
Ph not_applicable
9
23%
Ph phase_3
7
18%
Ph phase_2
16
41%

Phase Distribution

6

Early Stage

16

Mid Stage

8

Late Stage

Phase Distribution39 total trials
Phase 1Safety & dosage
6(15.4%)
Phase 2Efficacy & side effects
16(41.0%)
Phase 3Large-scale testing
7(17.9%)
Phase 4Post-market surveillance
1(2.6%)
N/ANon-phased studies
9(23.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

39 of 39 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

39

all time

Status Distribution
Completed(39)

Detailed Status

Completed39

Development Timeline

Analytics

Development Status

Total Trials
39
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 16 (15.4%)
Phase 216 (41.0%)
Phase 37 (17.9%)
Phase 41 (2.6%)
N/A9 (23.1%)

Trials by Status

completed39100%

Recent Activity

Clinical Trials (39)

Showing 20 of 39 trialsScroll for more
NCT00001032Phase 2

A Study of Dideoxycytidine Plus Zidovudine (AZT) in HIV-Infected Children Who Have Taken AZT

Completed
NCT00000997Not Applicable

A Study of Dideoxycytidine in HIV-Infected Patients

Completed
NCT00001029Phase 2

A Comparison of Three Treatments for Advanced HIV Disease in Patients Who Have Received Nucleoside Therapy in the Past

Completed
NCT00000754Phase 2

A Randomized Phase II Study of Two Doses of Interferon Alfa-2a (IFN Alfa-2a) in Combination With Zidovudine (AZT) and Dideoxycytidine (ddC) Versus AZT and ddC Only in Patients With HIV Infection and Less Than 400 CD4 Cells/mm3

Completed
NCT00000969Not Applicable

A Prospective, Randomized, Open-Label, Comparative Trial of Dideoxyinosine (ddI) Versus Dideoxycytidine (ddC) in HIV-Infected Patients Who Are Intolerant of or Who Have Failed Zidovudine (AZT) Therapy

Completed
NCT00000781Phase 2

A Randomized, Double-Blind, Four-Arm Study Comparing Combination Nucleoside, Alternating Nucleoside, and Triple-Drug Therapy for the Treatment of Advanced HIV Disease (CD4 <= 50/mm3)

Completed
NCT00001022Phase 3

A Comparison of Zidovudine (AZT) Used Alone or in Combination With Didanosine (ddI) or Dideoxycytidine (ddC) in HIV-Infected Patients

Completed
NCT00000753Phase 1

A Phase I Concentration-Targeted Multidose Study of Atevirdine Mesylate ( U-87201E ), AZT, and ddI or ddC

Completed
NCT00000718Not Applicable

A Clinical Trial of Alternating and Intermittent Regimens of 2',3'-Dideoxycytidine and 3'-Azido-3'-Deoxythymidine in the Treatment of Patients With AIDS and Advanced ARC

Completed
NCT00000704Phase 1

A Multicenter Dose Ranging Clinical Trial of 2',3'-Dideoxycytidine in the Treatment of Patients With AIDS and Advanced ARC.

Completed
NCT00000719Not Applicable

A Trial of Alternating 2',3'-Dideoxycytidine and Zidovudine in the Treatment of Patients With Advanced HIV Disease

Completed
NCT00000682Phase 3

A Randomized, Unblinded Trial of Zidovudine Versus ddC in the Treatment of Patients Status Post PCP Who Received Long-Term Zidovudine Therapy in Protocol ACTG 002

Completed
NCT00000625Phase 2

A Randomized, Double-Blind Phase II/III Trial of Monotherapy vs. Combination Therapy With Nucleoside Analogs in HIV-Infected Persons With CD4 Cells of 200-500/mm3

Completed
NCT00000651Phase 3

A Randomized, Double Blind, Comparative Study of Dideoxycytidine (ddC) Alone or ddC/AZT Combination Versus Zidovudine (ZDV) Alone in Patients With HIV Infection Who Have Received Prior ZDV Therapy

Completed
NCT00001087Phase 2

The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs

Completed
NCT00001048Phase 2

Comparison of Anti HIV Drugs Used Alone or in Combination With Cytosine Arabinoside to Treat Progressive Multifocal Leukoencephalopathy (PML) in HIV-Infected Patients

Completed
NCT00000954Phase 1

A Study of Chemotherapy Plus ddI or ddC in the Treatment of AIDS-Related Kaposi's Sarcoma

Completed
NCT00000902Phase 1

A Study on the Management of Combination Anti-HIV Drug Therapy in HIV-Positive Children With Prior Treatment

Completed
NCT00000653Phase 2

A Trial of Two Doses of 2',3'-Dideoxycytidine (ddC) in the Treatment of Children With Symptomatic HIV Infection Who Are Intolerant of AZT and/or Who Show Progressive Disease While on AZT

Completed
NCT00001035Phase 1

The Safety and Effectiveness of a Two-Drug Combination in the Treatment of Patients With Hepatitis C Plus Advanced HIV Infections

Completed

Drug Details

Intervention Type
DRUG
Total Trials
39